Estrogen reduces carbachol-induced constriction of asthmatic airways by stimulating large-conductance voltage and calcium-dependent potassium channels

American Journal of Respiratory Cell and Molecular Biology

Volumn 32, Issue 3, 2005, Pages 239-247

  Dimitropoulou, Christiana ^a   White, E ^a   Ownby, Dennis R ^a   Catravas, John D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Airway smooth muscle; Asthma; Estrogen; Large conductance voltage and calcium dependent potassium channels; Nitric oxide

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; CARBACHOL; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; ESTROGEN; GUANYLATE CYCLASE INHIBITOR; IBERIOTOXIN; KT 5823; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; QUINOXALINE DERIVATIVE; VOLTAGE GATED POTASSIUM CHANNEL; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL;

AIRWAY CONSTRICTION; ALLERGIC ASTHMA; ANIMAL CELL; ARTICLE; ASTHMA; BRONCHUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; INCIDENCE; MOUSE; NONHUMAN; PATCH CLAMP; SIGNAL TRANSDUCTION; TRACHEA; AIRWAY OBSTRUCTION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; METABOLISM;

ANIMALIA; BRONCHUS;

AIRWAY OBSTRUCTION; ANIMALS; BRONCHI; CARBACHOL; ESTROGENS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MICE; MICE, INBRED C57BL; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; TRACHEA;

EID: 15044340297     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2004-0331OC     Document Type: Article

References (44)

1. Skobeloff EM, Spivey WH, St. Clair SS, Schoffstall JM. The influence of age and sex on asthma admissions. JAMA 1992;268:3437-3440.
2. Zimmerman JL, Woodruff PG, Clark S, Camargo CA. Relation between phase of menstrual cycle and emergency department visits for acute asthma. Am J Respir Crit Care Med 2000;162:512-515.
3. Lieberman D, Kopernic G, Porath A, Levitas E, Lazer S, Heimer D. Influence of estrogen replacement therapy on airway reactivity. Respiration (Herrlisheim) 1995;62:205-208.
4. Beynon HL, Garbett ND, Barnes PJ. Severe premenstrual exacerbations of asthma: effect of intramuscular progesterone. Lancet 1988;2:370-372.
5. Frank R. The hormonal causes of pre-menstrual tension. Arch Neurol Psychiatry 1931;126:1053-1057.
6. Gibbs CJ, Coutts II, Lock R, Finnegan OC, White RJ. Premenstrual exacerbation of asthma. Thorax 1984;39:833-836.
7. Hanley SP. Asthma variation with menstruation. Br J Dis Chest 1981;75: 306-308.
8. Pauli BD, Reid RL, Munt PW, Wigle RD, Forkert L. Influence of the menstrual cycle on airway function in asthmatic and normal subjects. Am Rev Respir Dis 1989;140:358-362.
9. Chandler MH, Schuldheisz S, Phillips BA, Muse KN. Premenstrual asthma: the effect of estrogen on symptoms, pulmonary function, and beta 2-receptors. Pharmacotherapy 1997;17:224-234.
10. Matsuo N, Shimoda T, Matsuse H, Kohno S. A case of menstruation- associated asthma: treatment with oral contraceptives. Chest 1999;116: 252-253.
11. Juniper EF, Daniel EE, Roberts RS, Kline PA, Hargreave FE, Newhouse MT. Improvement in airway responsiveness and asthma severity during pregnancy: a prospective study. Am Rev Respir Dis 1989;140:924-931.
12. Johannesson M, Ludviksdottir D, Janson C. Lung function changes in relation to menstrual cycle in females with cystic fibrosis. Respir Med 2000;94:1043-1046.
13. Weinstein RE, Lobocki CA, Gravett S, Hum H, Negrich R, Herbst J, Greenberg D, Pieper DR. Decreased adrenal sex steroid levels in the absence of glucocorticoid suppression in postmenopausal asthmatic women. J Allergy Clin Immunol 1996;97:1-8.
14. Hasaneen NA, Foda HD, Said SI. Nitric oxide and vasoactive intestinal peptide as co-transmitters of airway smooth-muscle relaxation: analysis in neuronal nitric oxide synthase knockout mice. Chest 2003;124: 1067-1072.
15. Hakonarson H, Herrick DJ, Grunstein MM. Mechanism of impaired beta-adrenoceptor responsiveness in atopic sensitized airway smooth muscle. Am J Physiol 1995;269:L645-L652.
16. +) channels in human coronary artery smooth muscle cells. Cardiovasc Res 2002;53: 650-661.
17. Venema RC, Venema VJ, Ju H, Harris MB, Snead C, Jilling T, Dimitropoulou C, Maragoudakis ME, Catravas JD. Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase. Am J Physiol Heart Circ Physiol 2003;285:H669-H678.
18. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility, 7th ed. Baltimore, MD: Lippincott, Williams, and Wilkins; 2004.
19. Balzano G, Fuschillo S, Melillo G, Bonini S. Asthma and sex hormones. Allergy 2001;56:13-20.
20. Persson CG. Con: mice are not a good model of human airway disease. Am J Respir Crit Care Med 2002;166:6-7; discussion 8.
21. Kumar RK, Foster PS. Modeling allergic asthma in mice: pitfalls and opportunities. Am J Respir Cell Mol Biol 2002;27:267-272.
22. Gelfand EW. Pro: mice are a good model of human airway disease. Am J Respir Crit Care Med 2002;166:5-6; discussion 7-8.
23. Salari H, Yeung M, Howard S, Schellenberg RR. Increased contraction and inositol phosphate formation of tracheal smooth muscle from hyperresponsive guinea pigs. J Allergy Clin Immunol 1992;90:918-926.
24. Schatz M, Harden K, Forsythe A, Chilingar L, Hoffman C, Sperling W, Zeiger RS. The course of asthma during pregnancy, post partum, and with successive pregnancies: a prospective analysis. J Allergy Clin Immunol 1988;81:509-517.
25. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997;277:1508-1510.
26. White RE, Darkow DJ, Lang JL. Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism. Circ Res 1995;77:936-942.
27. Robertson JF, Odling-Smee W, Holcombe C, Kohlhardt SR, Harrison MP. Pharmacokinetics of a single dose of fulvestrant prolonged-release intramuscular injection in postmenopausal women awaiting surgery for primary breast cancer. Clin Ther 2003;25:1440-1452.
28. Belcher SM, Zsarnovszky A. Estrogenic actions in the brain: estrogen, phytoestrogens, and rapid intracellular signaling mechanisms. J Pharmacol Exp Ther 2001;299:408-414.
29. Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, Chavez JE, Mosher MD. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993;7:566-571.
30. Hellstrom WJ, Bell M, Wang R, Sikka SC. Effect of sodium nitroprusside on sperm motility, viability, and lipid peroxidation. Fertil Steril 1994;61: 1117-1122.
31. Xu KY, Huso DL, Dawson TM, Bredt DS, Becker LC. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci USA 1999;96:657-662.
32. Samb A, Pretolani M, Dinh-Xuan AT, Ouksel H, Callebert J, Lisdero C, Aubier M, Boczkowski J. Decreased pulmonary and tracheal smooth muscle expression and activity of type 1 nitric oxide synthase (nNOS) after ovalbumin immunization and multiple aerosol challenge in guinea pigs. Am J Respir Crit Care Med 2001;164:149-154.
33. Colasanti M, Suzuki H. The dual personality of NO. Trends Pharmacol Sci 2000;21:249-252.
34. Papapetropoulos A, Fulton D, Lin MI, Fontana J, McCabe TJ, Zoellner S, Garcia-Cardena G, Zhou Z, Gratton JP, Sessa WC. Vanadate is a potent activator of endothelial nitric-oxide synthase: evidence for the role of the serine/threonine kinase Akt and the 90-kDa heat shock protein. Mol Pharmacol 2004;65:407-415.
35. Ca, channels through a cGMP-dependent mechanism. Circ Res 1995;77:936-942.
36. Diano S, Horvath TL, Mor G, Register T, Adams M, Harada N, Naftolin F. Aromatase and estrogen receptor immunoreactivity in the coronary arteries of monkeys and human subjects. Menopause 1999;6:21-28.
37. Rosano GM, Caixeta AM, Chierchia S, Arie S, Lopez-Hidalgo M, Pereira WI, Leonardo F, Webb CM, Pileggi F, Collins P. Short-term anti-ischemic effect of 17beta-estradiol in postmenopausal women with coronary artery disease. Circulation 1997;96:2837-2841.
38. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, Bender JR. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 2000;87:677-682.
39. Best L. Inhibition of glucose-induced electrical activity by 4-hydroxytamoxifen in rat pancreatic beta-cells. Cell Signal 2002;14:69-73.
40. Kaczorowski GJ, Knaus HG, Leonard RJ, McManus OB, Garcia ML. High-conductance calcium-activated potassium channels; structure, pharmacology, and function. J Bioenerg Biomembr 1996;28:255-267.
41. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 1995;268:C799-C822.
42. +) channels in coronary smooth muscle during aging. Circ Res 2001;88:210-216.
43. + channel. J Biol Chem 2004;279:36746-36752.
44. Rosano GM, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 1993;342:133-136.